Keep Factually independent

Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.

Loading...Goal: 1,000 supporters
Loading...

Did regulatory changes during 2017–2020 alter nurse practitioner scope-of-practice or professional standing?

Checked on November 24, 2025
Disclaimer: Factually can make mistakes. Please verify important info or breaking news. Learn more.

Executive summary

Regulatory changes between 2017–2020 did alter nurse practitioner (NP) scope-of-practice in several ways: by 2017, 22 states plus D.C. already allowed full practice authority and during 2020 many states and the federal government issued temporary waivers or orders that loosened restrictions amid COVID-19 [1] [2]. Available sources document state-by-state legislation before 2017, academic analyses through 2020, and wide use of emergency executive orders in 2020 — but do not provide a single nationwide tally of permanent 2017–2020 statutory changes [1] [3] [2].

1. What changed on the ground: more freedom, especially during the COVID emergency

Researchers and policy reviewers report that in early 2020 federal action (CMS emergency declaration) and multiple governors’ executive orders temporarily removed or loosened scope-of-practice restrictions so NPs could “practice to the full extent of their license” to meet pandemic demand; many of those orders were rapid and state-specific [2]. Academic syntheses note the pandemic “generated an upheaval in state-level regulations” and prompted debate about making temporary changes permanent [4] [2].

2. Baseline going into 2017: big interstate variation

Before the 2017–2020 window, U.S. states already varied widely: as of March 2017, 22 states and Washington, D.C. allowed NPs to diagnose, treat, and prescribe without physician involvement while the rest imposed collaboration or supervision requirements [1]. Systematic reviews and state surveys emphasize that roughly half the states then restricted NP authority to some degree [3] [5].

3. Evidence and academic studies: scope changes affect access and workforce

Multiple peer-reviewed studies and reviews find that easing scope restrictions is associated with increased NP workforce participation, improved access to care, and no consistent harm to quality — findings that shaped advocacy and policy debates during 2017–2020 [6] [3] [7]. Journal of Nursing Regulation and other analyses summarized that removing regulatory barriers increases available NP workforce and access without reducing care quality [8].

4. Regulatory mechanics: how changes were implemented

Changes came through traditional legislation, board-level rulemaking, and emergency executive or CMS actions. For COVID specifically, CMS issued emergency authorization on March 30, 2020, and many governors used executive orders to relax state SOP rules; professional groups (AANP) tracked the rapidly changing state-level landscape [2]. Some regulatory updates, such as CMS rule revisions around preceptor documentation in 2019–2020, also adjusted administrative burdens affecting NP training and practice [9].

5. Which changes were temporary versus permanent — and where sources are silent

Sources clearly document many temporary pandemic-era waivers in 2020 and note debates over permanence [2] [4]. Academic and policy literature through 2021–2023 documents states moving toward full practice authority over time, but available reporting given for this query does not provide a comprehensive, state-by-state list of which 2017–2020 changes were later made permanent [5] [4]. In short: emergency deregulation happened in 2020; permanence varied by state and is not exhaustively cataloged in the provided sources [2] [4].

6. Stakeholder perspectives and the political frame

Proponents — including AANP and many workforce researchers — argue expanded scope eases primary-care shortages, yields economic benefits, and does not reduce quality [10] [8]. Opponents, including some physician organizations, raise training and patient-safety concerns; the American Medical Association and others have publicized investigations and critiques about NP education and independent practice [11] [12]. Reporting shows the debate is shaped by workforce shortages, cost pressures, and the priorities of advocacy organizations on both sides [1] [11].

7. Practical implications for patients and employers

Where regulation loosened — temporarily or permanently — states and health systems reported more flexible staffing, broader NP use in primary care and surge response, and calls from researchers to consider making some pandemic flexibilities permanent to sustain access [5] [2] [4]. At the same time, the AMA and others caution policymakers that expanded authority should be matched by attention to education and supervision quality [11] [12].

8. Bottom line and limits of this summary

The available sources show clear regulatory movement in 2017–2020: a varied pre-2017 baseline, incremental state reforms, and a notable 2020 surge of temporary waivers tied to COVID-19 that loosened NP scope-of-practice in many jurisdictions [1] [2] [4]. However, the materials provided do not contain a definitive, nationwide count of permanent statutory changes that were adopted in that 2017–2020 period; for a precise state-by-state legal timeline you will need consolidated legislative tracking or primary state statute records (not found in current reporting) [5] [2].

Want to dive deeper?
Which U.S. states expanded nurse practitioner independent practice between 2017 and 2020?
How did scope-of-practice regulatory changes from 2017–2020 affect NP prescribing authority, including controlled substances?
What impact did 2017–2020 regulatory reforms have on nurse practitioner reimbursement and credentialing with insurers and Medicare/Medicaid?
Did changes from 2017–2020 alter collaborative agreement requirements or physician supervision for nurse practitioners?
What evidence exists on patient access, quality of care, and workforce outcomes after NP scope-of-practice changes in 2017–2020?